The short version
8 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Leucovorin Calcium · LEUCOVORIN CALCIUM 350 mg/17.5mL · Injection, Powder, Lyophilized, For Solution · Intramuscular; Intravenous · Gland Pharma Limited
NDC 68083-0587-01 · 1 VIAL in 1 CARTON / 17.5 mL in 1 VIAL · ANDA · View full market →
8 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| BluePoint Laboratories | LEUCOVORIN CALCIUM 200 mg/20mL | Jul 15, 2026 | Sep 3, 2026 |
| BluePoint Laboratories | LEUCOVORIN CALCIUM 100 mg/10mL | Jul 15, 2026 | Sep 3, 2026 |
| Fresenius Kabi USA, LLC | LEUCOVORIN CALCIUM 200 mg/20mL | Jul 15, 2026 | Sep 3, 2026 |
| Hikma Pharmaceuticals USA Inc. | LEUCOVORIN CALCIUM 200 mg/20mL | Jul 15, 2026 | Sep 3, 2026 |
| Fresenius Kabi USA, LLC | LEUCOVORIN CALCIUM 500 mg/50mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | LEUCOVORIN CALCIUM 350 mg/17.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., Usa | LEUCOVORIN CALCIUM 350 mg/17.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | LEUCOVORIN CALCIUM 350 mg/17.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | LEUCOVORIN CALCIUM 50 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | LEUCOVORIN CALCIUM 100 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Meitheal Pharmaceuticals Inc. | LEUCOVORIN CALCIUM 100 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Meitheal Pharmaceuticals Inc. | LEUCOVORIN CALCIUM 500 mg/50mL | Jul 15, 2026 | Sep 2, 2026 |
| Meitheal Pharmaceuticals Inc. | LEUCOVORIN CALCIUM 50 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Meitheal Pharmaceuticals Inc. | LEUCOVORIN CALCIUM 350 mg/17.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Meitheal Pharmaceuticals Inc. | LEUCOVORIN CALCIUM 200 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | LEUCOVORIN CALCIUM 500 mg/50mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | LEUCOVORIN CALCIUM 100 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | LEUCOVORIN CALCIUM 200 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | LEUCOVORIN CALCIUM 350 mg/17.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | LEUCOVORIN CALCIUM 50 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Slate Run Pharmaceuticals, LLC | LEUCOVORIN CALCIUM 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Slate Run Pharmaceuticals, LLC | LEUCOVORIN CALCIUM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Slate Run Pharmaceuticals, LLC | LEUCOVORIN CALCIUM 350 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Slate Run Pharmaceuticals, LLC | LEUCOVORIN CALCIUM 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Slate Run Pharmaceuticals, LLC | LEUCOVORIN CALCIUM 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| BluePoint Laboratories | LEUCOVORIN CALCIUM 350 mg/17.5mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Leucovorin Calcium — NDC 68083-0587-01," retrieved September 3, 2026, https://drugdashboards.com/drug/68083058701.
Free to cite with attribution — see how the data is put together.